Glasgow Alcoholic Hepatitis Score

The Glasgow Alcoholic Hepatitis Score predicts short‑term mortality and identifies which patients with severe alcoholic hepatitis benefit from corticosteroids 1.

Age
Less than 50 y/o+1Greater than or equal to 50 y/o+2
[WBC] Count
WBC less than 15 x10^9/L+1WBC greater than or equal to 15 x10^9/L+2
[BUN]
Less than 5 mmol/L+1Greater than or equal to 5 mmol/L+2
[Bilirubin]
Less than 125 µmol/L+1125-250 µmol/L+2Greater than or equal to 250 µmol/L+3
[PT] ratio
Less than 1.5+11.5-2+2Greater than or equal to 2.0+3
seconds
seconds

Indicações de Uso

Used in adults with suspected or confirmed alcoholic hepatitis to stratify short‑term mortality risk and identify who benefits from corticosteroids. A score ≥9 indicates poor prognosis and, when paired with MDF ≥32, predicts survival benefit from prednisolone (28‑day mortality 52% untreated vs 78% treated; p=0.002) 1 [Level II evidence]. A score <9 indicates low short‑term mortality with no steroid benefit 2 [Level I evidence].

Insights e Precauções

Identifies severe cases (≥9) with high short‑term mortality and likely corticosteroid benefit, but accuracy is modest and geography‑limited. Validation shows improved 28‑/84‑day prognostic performance over mDF (AUC ~0.81 vs 0.49) 1 [Level II evidence], and steroid benefit only when ≥9 (28‑day survival 78% vs 52%; p=0.002) 2 [Level II evidence]. Not validated outside the UK and inferior to MELD in global cohorts. Use cautiously and always alongside clinical judgment.